Increased TLR2 expression in patients with type 1 diabetes: Evidenced risk of microalbuminuria

Pediatric Diabetes

Volumn 13, Issue 2, 2012, Pages 147-154

  Ururahy, Marcela Abbott Galvão ^a   Loureiro, Melina Bezerra ^a   Freire Neto, Francisco Paulo ^a   de Souza, Karla Simone Costa ^a   Zuhl, Irina ^b   Brandão Neto, José ^a   Hirata, Rosario Dominguez Crespo ^c   Doi, Sonia de Quateli ^d   Arrais, Ricardo Fernando ^a   Hirata, Mario Hiroyuki ^c   Almeida, Maria das Graças ^a   de Rezende, Adriana Augusto ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO NORTE   (Brazil)

^b CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d Uniformed Services University of the Health Sciences   (United States)

Author keywords

Inflammation; Microalbuminuria; Toll like receptors; Type 1 diabetes

Indexed keywords

CREATININE; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR ALPHA; UREA;

ADULT; ARTICLE; CHILD; CREATININE BLOOD LEVEL; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; INFLAMMATION; KIDNEY; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK ASSESSMENT; UREA BLOOD LEVEL;

ADOLESCENT; ALBUMINURIA; CHILD; CREATININE; CYTOKINES; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; LEUKOCYTES; MALE; MYELOID DIFFERENTIATION FACTOR 88; RISK; SERUM ALBUMIN; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; UREA; YOUNG ADULT;

EID: 84857503216     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/j.1399-5448.2011.00794.x     Document Type: Article

References (26)

1. Kanczkowski W, Ziegler CG, Zacharowski K, Bornstein SR. Toll-like receptors in endocrine disease and diabetes. Neuroimmunomodulation 2008: 15: 54-60.
2. Loiarro M, Ruggiero V, Sette C. Targeting TLR/IL-1R signalling in human diseases. Mediat Inflamm 2010: article ID: 674363.
3. Morran MP, Omenn GS, Pietropaolo M. Immunology and genetics of type 1 diabetes. Mt Sinai J Med 2008: 75: 314-327.
4. Kawai T, Akira S. The roles of TLRs, RLRs and NLRs in pathogen recognition. Int Immunol 2009: 21: 317-337.
5. Akira S. Pathogen recognition by innate immunity and its signaling. Proceedings of Japan Academy - series B. Phys Biol Sci 2009: 85: 143-156.
6. Erridge C. Endogenous ligands of TLR2 and TLR4: agonists or assistants? J Leukoc Biol 2010: 87: 989-999.
7. Ghanim H, Mohanty P, Deopurkar R et al. Acute modulation of toll-like receptors by insulin. Diabetes Care 2008: 31: 1827-1831.
8. Smith KD. Toll-like receptors in kidney disease. Curr Opin Nephrol Hypertens 2009: 18: 189-196.
9. Dasu MR, Devaraj S, Zhao L, Hwang DH, Jialal I. High glucose induces toll-like receptor expression in human monocytes: mechanism of activation. Diabetes 2008: 57: 3090-3098.
10. Foster SL, Medzhitov R. Gene-specific control of the TLR-induced inflammatory response. Clin Immunol 2009: 130: 7-15.
11. Zipris D. Innate immunity and its role in type 1 diabetes. Curr Opin Endocrinol Diabetes Obes 2008: 15: 326-331.
12. Navarro JF, Mora C, Muros M, Garcia J. Urinary tumour necrosis factor-alpha excretion independently correlates with clinical markers of glomerular and tubulointerstitial injury in type 2 diabetic patients. Nephrol Dial Transplant 2006: 21: 3428-3434.
13. Navarro-Gonzalez JF, Mora-Fernandez C. The role of inflammatory cytokines in diabetic nephropathy. J Am Soc Nephrol 2008: 19: 433-442.
14. Kaizer EC, Glaser CL, Chaussabel D, Banchereau J, Pascual V, White PC. Gene expression in peripheral blood mononuclear cells from children with diabetes. J Clin Endocrinol Metabol 2007: 92: 3705-3711.
15. Wang X, Jia S, Geoffrey R, Alemzadeh R, Ghosh S, Hessner MJ. Identification of a molecular signature in human type 1 diabetes mellitus using serum and functional genomics. J Immunol 2008: 180: 1929-1937.
16. Devaraj S, Dasu MR, Rockwood J, Winter W, Griffen SC, Jialal I. Increased toll-like receptor (TLR) 2 and TLR4 expression in monocytes from patients with type 1 diabetes: further evidence of a proinflammatory state. J Clin Endocrinol Metabol 2008: 93: 578-583.
17. Sherry CL, O'Connor JC, Kramer J, Freund GG. Augmented lipopolysaccharide-induced TNF-alpha production by peritoneal macrophages in type 2 diabetic mice is dependent on elevated glucose and requires p38 MAPK. J Immunol 2007: 178: 663-670.
18. Mohammad MK, Morran M, Slotterbeck B et al. Dysregulated toll-like receptor expression and signaling in bone marrow-derived macrophages at the onset of diabetes in the non-obese diabetic mouse. Int Immunol 2006: 18: 1101-1113.
19. Dogan Y, Akarsu S, Ustundag B, Yilmaz E, Gurgoze MK. Serum IL-1beta, IL-2, and IL-6 in insulin-dependent diabetic children. Mediat Inflamm 2006: 59206: 1-6.
20. Amin R, Widmer B, Prevost AT et al. Risk of microalbuminuria and progression to macroalbuminuria in a cohort with childhood onset type 1 diabetes: prospective observational study. Br Med J 2008: 336: 697-701.
21. American Diabetes Association. Standards of medical care in diabetes-2010. Diabetes Care 2010: 33: S11-S61.
22. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2 (-Delta Delta C (T)) method. Methods 2001: 25: 402-408.
23. Park Y, Park S, Yoo E, Kim D, Shin H. Association of the polymorphism for toll-like receptor 2 with type 1 diabetes susceptibility. Ann N Y Acad Sci 2004: 1037: 170-174.
24. Galassetti PR, Iwanaga K, Pontello AM, Zaldivar FP, Flores RL, Larson JK. Effect of prior hyperglycemia on IL-6 responses to exercise in children with type 1 diabetes. Am J Physiol Endocrinol Metabol 2006: 290: E833-E839.
25. Rosa JS, Flores RL, Oliver SR, Pontello AM, Zaldivar FP, Galassetti PR. Resting and exercise-induced IL-6 levels in children with type 1 diabetes reflect hyperglycemic profiles during the previous 3 days. J Appl Physiol 2010: 108: 334-342.
26. Bogdanovic R. Diabetic nephropathy in children and adolescents. Pediatr Nephrol 2008: 23: 507-525.